Quantinno Capital Management LP Acquires 17,543 Shares of Relx Plc (NYSE:RELX)

Quantinno Capital Management LP increased its position in shares of Relx Plc (NYSE:RELX - Free Report) by 11.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 171,219 shares of the technology company's stock after buying an additional 17,543 shares during the quarter. Quantinno Capital Management LP's holdings in Relx were worth $7,777,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. CENTRAL TRUST Co boosted its stake in shares of Relx by 1,290.2% in the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock valued at $26,000 after buying an additional 529 shares in the last quarter. Transce3nd LLC purchased a new stake in shares of Relx in the fourth quarter valued at $40,000. Sierra Ocean LLC purchased a new stake in Relx during the fourth quarter valued at about $43,000. Brown Brothers Harriman & Co. boosted its position in shares of Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after buying an additional 662 shares during the period. Finally, Private Trust Co. NA boosted its position in shares of Relx by 19.2% in the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after buying an additional 199 shares during the period. Hedge funds and other institutional investors own 15.02% of the company's stock.

Relx Price Performance

NYSE RELX traded up $0.39 during trading on Wednesday, reaching $55.38. 411,601 shares of the company traded hands, compared to its average volume of 705,284. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The stock's 50 day moving average price is $51.43 and its two-hundred day moving average price is $49.02. The company has a market cap of $102.22 billion, a price-to-earnings ratio of 29.77, a P/E/G ratio of 2.73 and a beta of 0.86. Relx Plc has a 1-year low of $43.28 and a 1-year high of $55.57.

Wall Street Analyst Weigh In

RELX has been the topic of a number of research reports. The Goldman Sachs Group began coverage on Relx in a research report on Wednesday, March 26th. They set a "buy" rating on the stock. Morgan Stanley restated an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. Barclays upgraded Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. Finally, StockNews.com downgraded Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Buy".

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.